The first generic formulations of the [beta]-blocker carvedilol (Coreg) have been approved by the Food and Drug Administration for treating hypertension, mild to severe chronic heart failure, and left ventricular dysfunction following a myocardial infar…
The label of Coreg (carvedilol) has been changed to include data from two clinical trials that show reduced risk of repeat MI and reduced risk of MI in heart failure patients. Patients participating the Ca…
Advair HFA inhalation is now on the market. Manufactured by GlaxoSmithKline PLC, the medicine is used to treat asthma. The FDA has also approved the company’s Coreg for treating hypertension, post-myocardial infarction left ventricular dysfunction, and mild-to-severe heart attack.
Related Results
Trial data added to coreg labelNew indications for once-daily CoregFlamel Tech…
